Report Detail
Global Biopharmaceutical CMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM3977437 |
- 19 February, 2023 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Biopharmaceutical CMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biopharmaceutical CMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biopharmaceutical CMO Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biopharmaceutical CMO Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biopharmaceutical CMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biopharmaceutical CMO Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biopharmaceutical CMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biopharmaceutical CMO Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie and JRS Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biopharmaceutical CMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Market segment by Application
Clinical Manufacturing
Commercial Manufacturing
Others
Market segment by players, this report covers
Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biopharmaceutical CMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biopharmaceutical CMO Services, with revenue, gross margin and global market share of Biopharmaceutical CMO Services from 2018 to 2023.
Chapter 3, the Biopharmaceutical CMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biopharmaceutical CMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceutical CMO Services.
Chapter 13, to describe Biopharmaceutical CMO Services research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Biopharmaceutical CMO Services
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Biopharmaceutical CMO Services by Type
- 1.3.1 Overview: Global Biopharmaceutical CMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Biopharmaceutical CMO Services Consumption Value Market Share by Type in 2022
- 1.3.3 Biologics Manufacturing
- 1.3.4 Biosimilars Manufacturing
- 1.3.5 Others
- 1.4 Global Biopharmaceutical CMO Services Market by Application
- 1.4.1 Overview: Global Biopharmaceutical CMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Clinical Manufacturing
- 1.4.3 Commercial Manufacturing
- 1.4.4 Others
- 1.5 Global Biopharmaceutical CMO Services Market Size & Forecast
- 1.6 Global Biopharmaceutical CMO Services Market Size and Forecast by Region
- 1.6.1 Global Biopharmaceutical CMO Services Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Biopharmaceutical CMO Services Market Size by Region, (2018-2029)
- 1.6.3 North America Biopharmaceutical CMO Services Market Size and Prospect (2018-2029)
- 1.6.4 Europe Biopharmaceutical CMO Services Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Biopharmaceutical CMO Services Market Size and Prospect (2018-2029)
- 1.6.6 South America Biopharmaceutical CMO Services Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Biopharmaceutical CMO Services Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Lonza
- 2.1.1 Lonza Details
- 2.1.2 Lonza Major Business
- 2.1.3 Lonza Biopharmaceutical CMO Services Product and Solutions
- 2.1.4 Lonza Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Lonza Recent Developments and Future Plans
- 2.2 Boehringer Ingelheim
- 2.2.1 Boehringer Ingelheim Details
- 2.2.2 Boehringer Ingelheim Major Business
- 2.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Product and Solutions
- 2.2.4 Boehringer Ingelheim Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
- 2.3 AGC Biologics
- 2.3.1 AGC Biologics Details
- 2.3.2 AGC Biologics Major Business
- 2.3.3 AGC Biologics Biopharmaceutical CMO Services Product and Solutions
- 2.3.4 AGC Biologics Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 AGC Biologics Recent Developments and Future Plans
- 2.4 Rentschler Biotechnologie
- 2.4.1 Rentschler Biotechnologie Details
- 2.4.2 Rentschler Biotechnologie Major Business
- 2.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Product and Solutions
- 2.4.4 Rentschler Biotechnologie Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Rentschler Biotechnologie Recent Developments and Future Plans
- 2.5 JRS Pharma
- 2.5.1 JRS Pharma Details
- 2.5.2 JRS Pharma Major Business
- 2.5.3 JRS Pharma Biopharmaceutical CMO Services Product and Solutions
- 2.5.4 JRS Pharma Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 JRS Pharma Recent Developments and Future Plans
- 2.6 Catalent
- 2.6.1 Catalent Details
- 2.6.2 Catalent Major Business
- 2.6.3 Catalent Biopharmaceutical CMO Services Product and Solutions
- 2.6.4 Catalent Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Catalent Recent Developments and Future Plans
- 2.7 Biomeva
- 2.7.1 Biomeva Details
- 2.7.2 Biomeva Major Business
- 2.7.3 Biomeva Biopharmaceutical CMO Services Product and Solutions
- 2.7.4 Biomeva Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Biomeva Recent Developments and Future Plans
- 2.8 Samsung BioLogics
- 2.8.1 Samsung BioLogics Details
- 2.8.2 Samsung BioLogics Major Business
- 2.8.3 Samsung BioLogics Biopharmaceutical CMO Services Product and Solutions
- 2.8.4 Samsung BioLogics Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Samsung BioLogics Recent Developments and Future Plans
- 2.9 AbbVie
- 2.9.1 AbbVie Details
- 2.9.2 AbbVie Major Business
- 2.9.3 AbbVie Biopharmaceutical CMO Services Product and Solutions
- 2.9.4 AbbVie Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 AbbVie Recent Developments and Future Plans
- 2.10 Binex
- 2.10.1 Binex Details
- 2.10.2 Binex Major Business
- 2.10.3 Binex Biopharmaceutical CMO Services Product and Solutions
- 2.10.4 Binex Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Binex Recent Developments and Future Plans
- 2.11 WuXi Biologics
- 2.11.1 WuXi Biologics Details
- 2.11.2 WuXi Biologics Major Business
- 2.11.3 WuXi Biologics Biopharmaceutical CMO Services Product and Solutions
- 2.11.4 WuXi Biologics Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 WuXi Biologics Recent Developments and Future Plans
- 2.12 PRA Health Sciences
- 2.12.1 PRA Health Sciences Details
- 2.12.2 PRA Health Sciences Major Business
- 2.12.3 PRA Health Sciences Biopharmaceutical CMO Services Product and Solutions
- 2.12.4 PRA Health Sciences Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 PRA Health Sciences Recent Developments and Future Plans
- 2.13 ProBioGen
- 2.13.1 ProBioGen Details
- 2.13.2 ProBioGen Major Business
- 2.13.3 ProBioGen Biopharmaceutical CMO Services Product and Solutions
- 2.13.4 ProBioGen Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 ProBioGen Recent Developments and Future Plans
- 2.14 KBI Biopharma
- 2.14.1 KBI Biopharma Details
- 2.14.2 KBI Biopharma Major Business
- 2.14.3 KBI Biopharma Biopharmaceutical CMO Services Product and Solutions
- 2.14.4 KBI Biopharma Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 KBI Biopharma Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Biopharmaceutical CMO Services Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Biopharmaceutical CMO Services by Company Revenue
- 3.2.2 Top 3 Biopharmaceutical CMO Services Players Market Share in 2022
- 3.2.3 Top 6 Biopharmaceutical CMO Services Players Market Share in 2022
- 3.3 Biopharmaceutical CMO Services Market: Overall Company Footprint Analysis
- 3.3.1 Biopharmaceutical CMO Services Market: Region Footprint
- 3.3.2 Biopharmaceutical CMO Services Market: Company Product Type Footprint
- 3.3.3 Biopharmaceutical CMO Services Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Biopharmaceutical CMO Services Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Biopharmaceutical CMO Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Biopharmaceutical CMO Services Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Biopharmaceutical CMO Services Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Biopharmaceutical CMO Services Consumption Value by Type (2018-2029)
- 6.2 North America Biopharmaceutical CMO Services Consumption Value by Application (2018-2029)
- 6.3 North America Biopharmaceutical CMO Services Market Size by Country
- 6.3.1 North America Biopharmaceutical CMO Services Consumption Value by Country (2018-2029)
- 6.3.2 United States Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 6.3.3 Canada Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Biopharmaceutical CMO Services Consumption Value by Type (2018-2029)
- 7.2 Europe Biopharmaceutical CMO Services Consumption Value by Application (2018-2029)
- 7.3 Europe Biopharmaceutical CMO Services Market Size by Country
- 7.3.1 Europe Biopharmaceutical CMO Services Consumption Value by Country (2018-2029)
- 7.3.2 Germany Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 7.3.3 France Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 7.3.5 Russia Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 7.3.6 Italy Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Biopharmaceutical CMO Services Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Biopharmaceutical CMO Services Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region
- 8.3.1 Asia-Pacific Biopharmaceutical CMO Services Consumption Value by Region (2018-2029)
- 8.3.2 China Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 8.3.3 Japan Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 8.3.5 India Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 8.3.7 Australia Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Biopharmaceutical CMO Services Consumption Value by Type (2018-2029)
- 9.2 South America Biopharmaceutical CMO Services Consumption Value by Application (2018-2029)
- 9.3 South America Biopharmaceutical CMO Services Market Size by Country
- 9.3.1 South America Biopharmaceutical CMO Services Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Biopharmaceutical CMO Services Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Biopharmaceutical CMO Services Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country
- 10.3.1 Middle East & Africa Biopharmaceutical CMO Services Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
- 10.3.4 UAE Biopharmaceutical CMO Services Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Biopharmaceutical CMO Services Market Drivers
- 11.2 Biopharmaceutical CMO Services Market Restraints
- 11.3 Biopharmaceutical CMO Services Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Biopharmaceutical CMO Services Industry Chain
- 12.2 Biopharmaceutical CMO Services Upstream Analysis
- 12.3 Biopharmaceutical CMO Services Midstream Analysis
- 12.4 Biopharmaceutical CMO Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Biopharmaceutical CMO Services. Industry analysis & Market Report on Biopharmaceutical CMO Services is a syndicated market report, published as Global Biopharmaceutical CMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Biopharmaceutical CMO Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
